These results suggest a higher safety profile than previously reported in toxicity studies of PD‐1/PDL‐1 blockade for MCC (20%–30%),15, 19 especially given the nature of the population: elderly (mean age 74) and immune‐suppressed (22%). This evidence concerns the gene CD274 and Merkel cell skin cancer.